DiPalma Stephen J. 4
4 · Inozyme Pharma, Inc. · Filed May 18, 2021
Insider Transaction Report
Form 4
DiPalma Stephen J.
Interim CFO
Transactions
- Award
Stock option (Right to Buy)
2021-05-17+15,000→ 15,000 totalExercise: $15.90Exp: 2031-05-16→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option was granted on May 17, 2021 and will vest as to 50% of the shares underlying the option on the date that is 180 days following the grant date and as to the remaining 50% of the shares underlying the option on the first anniversary of the grant date, provided Mr. DiPalma is providing services to the Company on such dates.